Overall, there were no strong associations between starting levels or trajectories of inflammatory markers (IL-6, IL-10, TNF-α, MCP, IP-10, IFN-α, and TFN-γ) during the acute phase and the later development of PASC within this outpatient cohort. This evidence concerns the gene IL10 and long COVID-19.